|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Pharmaceuticals in South Korea |
|
|
|
|
€ 200,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2008 |
Taille du document : |
32 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 86 pages | Août 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,pharmacovigilance
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,united kingdom,india,germany,thailand,nigeria,... |
| |
|
|
|
|
| 127 pages | Mai 2003 | Anglais
|
|
|
| Main
focus: |
health expenditure,health insurance,...,hospitals,...
|
| Research
focus: |
market segmentation,demand analysis,market outlook, |
| Geographic
focus: |
australia,japan,usa,new zealand,france,canada,... |
| |
|
|
|
|
| 64 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,atherosclerosis,hypertension
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada |
| |
|
|
|
|
| 64 pages | Novembre 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,dyslipidemia,pharmaceutical,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada,poland |
| |
|
|
|
|
| 70 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
india,usa,china,france,united kingdom,malaysia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs 119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike. A great need exists for ph |
795,00 €
|
| |
| |
Generic Pharmaceutical Outlook 1998-2008 190 pages | Octobre 1998 |
Currently estimated to account for approximately 11% of Global pharmaceutical sales, this figure looks set to rise dramatically as branded drugs come off-patent within the next decade. Imminent |
795,00 €
|
| |
| |
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth 173 pages | Mars 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years. Where once near unrestricted revenue expansion existed, external pressures now act in unison |
955,00 €
|
| |
| |
The Pharmaceutical Outsourcing Outlook 1998-2003 199 pages | Juin 1999 |
The streamlining of pharmaceutical companies that has taken place in recent years has allowed them to focus resources and investment on core specialities. This, in turn, has led to a greater re |
795,00 €
|
| |
| |
The Drug Delivery Outlook 2001 176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery. Subseque |
955,00 €
|
| |
| |
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis 188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
|
1 200,00 €
|
| |
| |
The Pharmaceutical Industry Online 88 pages | Juillet 2002 |
In the United States, eMarketer projects that business-to-business e-commerce trade will grow to $1.3 trillion by 2005, while online trade in the health car |
800,00 €
|
| |
| |
Healthcare In Wales 50 pages | Mai 2000 |
The Welsh Presentation Includes:- The Structure Of The NHS In Wales- Revenue Expenditure On Health Services In Wales- Number Of Hospital Units - Number Of Available Inpatient Beds- Number Of Occupied |
327,00 €
|
| |
| |
The UK piling Market 40 pages | Mai 2002 |
This report will enable you to:Analyse the size of the UK market for piling between 1997 and 2006Quantify the size of the UK market for piling, 1997-2006, by technique: - bored - driven - embedded |
365,00 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave 160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
|
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Pharmaceuticals in South Korea |
|
|
Datamonitor's Pharmaceuticals in South Korea industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by value and/or volume
* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer or brand Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
|
|
TABLE OF CONTENTS EXECUTIVE SUMMARY 3 CHAPTER 1 Market Overview 7 1.1 Market Definition 7 1.2 Research Highlights 7 1.3 Market Analysis 8 CHAPTER 2 Market Value 9 CHAPTER 3 Market Segmentation I 10 CHAPTER 4 Market Segmentation II 11 CHAPTER 5 Market Share 12 CHAPTER 6 Five Forces Analysis 13 6.1 Summary 13 6.2 Buyer Power 14 6.3 Supplier Power 15 6.4 New Entrants 17 6.5 Substitutes 18 6.6 Rivalry 19
CHAPTER 7 Leading Companies 20 7.1 Dong-A Pharmaceutical Co. Ltd 20 7.2 Pfizer Korea 22 7.3 Handok Pharmaceuticals Co. Ltd. 24 7.4 Daewoong Pharmaceutical Co Ltd. 26 CHAPTER 8 Market Forecasts 28 8.1 Market Value Forecast 28 CHAPTER 9 Macroeconomic Indicators 29 CHAPTER 10 Appendix 31 10.1 Methodology 31 10.2 Industry Associations 32 10.3 Related Datamonitor Research 32 LIST OF TABLES Table 1: South Korea Pharmaceuticals Market Value: $ million, 2003-2007 9 Table 2: South Korea Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10 Table 3: South Korea Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11 Table 4: South Korea Pharmaceuticals Market Share: % Share, by Value, 2007 12 Table 5: Key Facts: Dong-A Pharmaceutical Co. Ltd. 20 Table 6: Key Facts: Pfizer Inc 22 Table 7: Key Financials: Pfizer Inc 23 Table 8: Key Facts: Handok Pharmaceuticals Co. Ltd. 24 Table 9: Key Financials: Handok Pharmaceuticals Co. Ltd. 25 Table 10: Key Facts: Daewoong Pharmaceutical Co Ltd. 26 Table 11: South Korea Pharmaceuticals Market Value Forecast: $ million, 2007-2012 28 Table 12: South Korea Size of Population (million) , 2003-2007 29 Table 13: South Korea GDP (Constant 2000 Prices, $ billion), 2003-2007 29 Table 14: South Korea Inflation, 2003-2007 29 Table 15: South Korea Exchange Rate, 2003 30
|
|
|
PPLSEN
|
|
|
|
|